Non-enzymatic model glycation reactions - A comprehensive study of the reactivity of a modified arginine with aldehydic and diketonic dicarbonyl compounds by electrospray mass spectrometry

Journal of Mass Spectrometry

Volumn 41, Issue 6, 2006, Pages 755-770

  Saraiva, Marco A ^a   Borges, Carlos M ^a   Florêncio, M Helena ^a  

^a UNIVERSITY OF LISBON   (Portugal)

Author keywords

dicarbonyls; Acetyl arginine; Advanced glycation end products; Electrospray mass spectrometry; Non enzymatic model glycation reactions

Indexed keywords

AMINO ACIDS; DISEASES; ENZYMES; MASS SPECTROMETRY; ORGANIC COMPOUNDS; PATHOLOGY;

Α-DICARBONYLS; ACETYL-ARGININE; ADVANCED GLYCATION END PRODUCTS(AGES); ELECTROSPRAY MASS SPECTROMETRY; NON-ENZYMATIC MODEL GLYCATION REACTIONS;

REACTION KINETICS;

2,3 BUTANEDIONE; ACETIC ACID DERIVATIVE; ACETYL 5 METHYLIMIDAZOLONE; ACETYL ARGPYRIMIDINE; ACETYL HYDROIMIDAZOLONE; ADVANCED GLYCATION END PRODUCT; ALDEHYDE; AMINO ACID; ARGININE; BICARBONATE; DIKETONE; GLYOXAL; METHYLGLYOXAL; N ACETYLARGININE; PHENYLGLYOXAL; UNCLASSIFIED DRUG;

AGING; ALZHEIMER DISEASE; ARTICLE; CHEMICAL MODIFICATION; CHEMICAL STRUCTURE; DIABETES MELLITUS; ELECTROSPRAY MASS SPECTROMETRY; FRAGMENTATION REACTION; GLYCATION; HYDRATION; IONIZATION; PRIORITY JOURNAL; PROTON TRANSPORT; TANDEM MASS SPECTROMETRY;

ALDEHYDES; ARGININE; CARBON; ENZYMES; GLYCOSYLATION END PRODUCTS, ADVANCED; KETONES; KINETICS; MODELS, CHEMICAL; SPECTROMETRY, MASS, ELECTROSPRAY IONIZATION;

EID: 33745779635     PISSN: 10765174     EISSN: 10969888     Source Type: Journal    
DOI: 10.1002/jms.1031     Document Type: Article

References (60)

1. Maillard L-C. Action des acides aminés sur les sucres: formation des mélanoidines por voie méthodique. C. R. Hebd. Seances Acad. Sci. Ser. 1912; 154: 66.
2. McCance DR, Dyer DG, Dunn JA, Baiue KE, Thorpe SR, Baynes JW, Lyons TJ. Maillard reaction products and their relation to complications in insulin-dependent diabetes mellitus. J. Clin. Invest. 1993; 91: 2470.
3. Lyons TJ, Silvestri G, Dunn JA, Dyer DG, Baynes JW. Role of glycation in modification of lens crystalline in diabetic and nondiabetic senile cataracts. Diabetes 1991; 40: 1010.
4. Vlassara H, Fuh H, Makita Z, Krungkrai S, Cerami A, Bucala R. Exogenous advanced glycosylation end products induce complex vascular dysfunctions in normal animals: a model for diabetic and aging complications. Proc. Natl. Acad. Sci. USA 1992; 89: 12043.
5. Vitek MP, Bhattyacharya K, Glendening JM, Stopa E, Vlassara H, Bucala R, Manogue K, Cerami A. Advanced glycation end products contribute to amyloidosis in Alzheimer disease. Proc. Natl. Acad. Sci. USA 1994; 91: 4766.
6. Miyata T, Oda O, Inagi R, Lida Y, Araki N, Yamada N, Horiuchi S, Taniguichi N, Maeda K. b2-Microglobulin modified with advanced glycation end products is a major component of haemodialysis-associated amyloidosis. J. Clin. Invest. 1993; 92: 1242.
7. Lee K-G, Shibamoto T. Toxicology and antioxidant activities of non-enzymatic browning reaction products: review. Food Rev. Int. 2002; 18: 151.
8. Tessier FJ, Monnier VM, Sayre LM, Kornfield JA. Triosidines: novel Maillard reaction products and cross-links from the reaction of triose sugars with lysine and arginine residues. Biochem. J. 2003; 369: 705, DOI: 10.1042/BJ20020668.
9. Ahmed N, Thornalley PJ. Chromatographic assay of glycation adducts in human serum albumin glycated in vitro by derivatization with 6-aminoquinolyl-N-hydroxysuccinimidyl-carbamate and intrinsic fluorescence. Biochem. J. 2002; 364: 15.
10. Sell DR, Monnier VM. Structural elucidation of senescence cross-link from human extra-cellular matrix: implication of pentoses in the aging process. J. Biol. Chem. 1989; 264: 21597.
11. Hayase F, Nagaraj RH, Myata S, Njoroge FG, Monnier VM. Aging of proteins: immunological detection of a glucose-derived pyrrole formed during Maillard reaction in vivo. J. Biol. Chem. 1989; 264: 3758.
12. α-CBZ-lysine by methylglyoxal. Bioorg. Med. Chem. Lett. 1996; 6: 1577.
13. Oya T, Hattori N, Mizuno Y, Miyata S, Maeda S, Osawa T, Uchida K. Methylglyoxal modification of protein. Chemical and immunochemical characterization of methylglyoxal-arginine adducts. J. Biol. Chem. 1999; 274: 18492.
14. ε- carboxymethyllysine as a degradation product of fructoselysine in glycated protein. J. Biol. Chem. 1986; 261: 4889.
15. ε-(Carboxyethyl)lysine, a product of the chemical modification of proteins by methylglyoxal, increases with age in human lens proteins. Biochem. J. 1997; 324: 565.
16. Konishi Y, Hayase F, Kato H. Novel imidazolone compound formed by the advanced Maillard reaction of 3-deoxyglucosone and arginine residues in proteins. Biosci. Biotechnol. Biochem. 1994; 58: 1953.
17. Hayase F, Konishi Y, Kato H. Identification of the modified structure of arginine residue in proteins with 3-deoxyglucosone, a Maillard reaction intermediate. Biosci. Biotechnol. Biochem. 1995; 59: 1407.
18. α-acetyllysine, and serum bovine albumin. J. Biol. Chem. 1994; 269: 32299.
19. Henle T, Walter AW, Haessner R, Klostermeyer H. Detection and identification of a protein-bound imidazolone resulting from the reaction of arginine residues and methylglyoxal. Z. Lebensm.-Unters.-Forsch. 1994; 199: 55.
20. Schwarzenbolz U, Henle T, Haessner R, Klostermeyer A. On the reaction of glyoxal with proteins. Z. Lebensm.-Unters.-Forsch. 1997; 205: 121.
21. α- hippuryllysine: a model for Maillard reaction crosslink in proteins. J. Org. Chem. 1995; 60: 6246.
22. α-hippuryllysine. J. Chem. Soc., Perkin. Trans. 1 1995; 2817.
23. Thornalley PJ, Langbord A, Minhas HS. Formation of glyoxal, methylglyoxal and 3-deoxyglucosone in the glycation of proteins by glucose. Biochem. J. 1999; 344: 109.
24. Lacovella GM, Alderson NL, Thorpe SR, Baynes JW. The role of reactive α-dicarbonyls in AGE/ALE formation and implication in diabetic complications. South Carolina Journal of Molecular Medicine 2004; 5: 73.
25. ε-(carboxyethyl)lysine, a product of the chemical modification of proteins by methylglyoxal increases with age in human lens proteins. Biochem. J. 1997; 324: 565.
26. Murata-Kamiya M, Kamiya H. Methylglyoxal, and endogenous aldehyde, crosslinks DNA polymerase and the substrate DNA. Nucleic Acids Res. 2001; 29: 3433, DOI: 10.1093/nar/29.16.3439.
27. Wells-Knecht KJ, Zyzak DV, Litchfield JE, Thorpe SR, Baynes JW. Mechanism of autoxidative glycosylation: identification of glyoxal and arabinose as intermediates in the autoxidative modification of proteins by glucose. Biochemistry 1995; 34: 3702.
28. ε-(carboxymethyl)lysine, is a product of both lipid peroxidation and glycoxidation reactions. J. Biol. Chem. 1996; 271: 9982.
29. Anderson MM, Hazen SL, Hsu FF, Heinecke JW. Human neutrophilis employ the mieloperoxidase-hydrogen peroxidechloride system to convert hydroxy-amino acids into glycolaldehyde, 2-hydroxypropanal, and acrolein. A mechanism for the generation of highly reactive α-hydroxy and α,β-unsaturated aldehydes by phagocytes at sites of inflammation. J. Clin. Invest. 1997; 99: 424.
30. Cotham WE, Metz TO, Fergunson PL, Brock JWC, Hinton DJS, Thorpe SR, Baynes JW, Ames JM. Proteomic analysis of arginine adducts on glyoxal-modified ribunoclease. Mol. Cell. Proteomics 2004; 3: 1145, DOI: 10.1074/mcp.M400002- MCP200.
31. Miller AG, Meade SJ, Gerrard JA. New insights into protein crosslinking via the Maillard reaction: structural requirements, the effect on enzyme function, and predicted efficacy of crosslinking inhibitors as anti-ageing therapeutics. Bioorg. Med. Chem. 2003; 11: 843, DOI: 10.1016/80968-0896(02) 00565-5.
32. Saraiva MA, Borges CM, Florêncio MH. Reactions of a modified lysine with aldehydic and ketonic dicarbonyl compounds: an electrospray mass spectrometry structure activity study. J. Mass. Spectrom. 2006; 41: 216.
33. Takahashi K. The reaction of phenylglyoxal with arginine residues in proteins. J. Biol. Chem. 1968; 243: 6171.
34. Grossberg AL, Pressman D. Modification of arginine in the active sites of antibodies. Biochemistry 1968; 7: 272.
35. Yankeelov JA Jr. Modification of arginine in proteins by oligomers of 2,3-butanedione. Biochemistry 1970; 9: 2433.
36. Yankeelov JA Jr. Modifications of arginine by diketones. J. Methods Enzymol. 1972; 15: 566.
37. Gacesa P, Savitsky MJ, Dogson KS, Olavensen AH. Modification of functional arginine residues in purified bovine testicular hyaluronidase with butane-2,3-dione. Biochim. Biophys. Acta-Enzymol. 1981; 661: 205.
38. Inano H, Ohba H, Tamaoki B-I. Photochemical inactivation of human placent al estradiol 17β-dehydrogenase in the presence of 2,3-butanedione. J. Steroid Biochem. 1983; 19: 1617.
39. Meade SJ, Miller AG, Gerrard JA. The role of dicarbonyl compounds in non-enzymatic crosslinking: a structure-activity study. Bioorg. Med. Chem. 2003; 11: 853, DOI: 10.1016/S0968-089(02)00564-3.
40. α-acetyl-L-lysinamide and glucose by electrospray mass spectrometry. Rapid Commun. Mass Spectrom. 1995a; 9: 69.
41. Lapolla A, Fedele D, Traldi P. The role of mass spectrometry in the study of non-enzymatic protein glycation in diabetes. Mass Spectrom. Rev. 2000; 19: 279, DOI: 10.1002/1098-2787(2000)19:5.
42. Lapolla A, Fedele D, Traldi P. Diabetes and mass spectrometry. Diabetes Metab. Res. Rev. 2001; 17: 99. DOI: 10.1002/dmrr.189.
43. Odani H, Matsumoto Y, Shinzato T, Usami J, Maeda K. Mass spectrometric study on the protein chemical modification of uremic patients in advanced Maillard reaction. J. Chromatogr., B 1999; 731: 131.
44. Ahmed N, Thornalley PJ. Quantitative screening of protein biomarkers of early glycation, advanced glycation, oxidation and nitrosation in cellular and extracellular proteins by tandem mass spectrometry multiple reaction monitoring. Biochem. Soc. Trans. 2003; 31: 1417.
45. Thornalley PJ, Battah S, Ahmed N, Karachalias N, Agalou S, Babaei-Jadidi R, Dawnay A. Quantitative screening of advanced glycation end products in cellular and extracellular proteins by tandem mass spectrometry. Biochem. J. 2003; 375: 581, DOI: 10.1042/BJ20030763.
46. Pourmotabbed T, Creighton DJ. Substrate specificity of bovine liver formaldehyde dehydrogenase. J. Biol. Chem. 1986; 261: 14240.
47. 1H NMR and a computer model. Eur. J. Biochem. 1990; 193: 83.
48. Kellum MW, Oray B, Norton SJ. A convenient quantitative synthesis of methylglyoxal for glyoxalase I assays. Anal. Biochem. 1978; 85: 586.
49. Martins SIFS. Unravelling the Maillard reaction network by multiresponse kinetic modelling. Ph.D. Thesis. Wageningen University, The Netherlands, 2003.
50. Glomb M, Lang G. Isolation and characterization of glyoxal-arginine modifications. J. Agric. Food Chem. 2001; 49: 1493, DOI: 10.1021/jf001082d.
51. ω-carboxymethylarginine as a novel acid-lable advanced glycation end product in collagen. Biochem. J. 2000; 347: 23.
52. Gruber P, Hofmann T. Chemoselective synthesis of peptides containing major advanced glycation end-products of lysine and arginine. J. Pept. Res. 2005; 66: 111.
53. ω- carboxymethylarginine, a new advanced glycation endproduct in serum proteins of diabetic patients: possibility of a new marker of aging and diabetes. Biochem. Biophys. Res. Commun. 2001; 285: 1232, DOI: 10.1006/bbrc.2001.5322.
54. ε-(1-carboxyethyl)lysine-modified albumin. Biochem. J. 2002; 264: 1.
55. Paul RG, Avery NC, Slatter DA, Sims TJ, Bailey AJ. Isolation and characterization of advanced glycation end products derived from the in vitro reaction of ribose and collagen. Biochem. J. 1998; 330: 1241.
56. Saraiva MA, Borges CM, Florencio MH, (in preparation).
57. Shipanova IN, Glomb MA, Nagaraj RH. Protein modification by methylglyoxal: chemical nature and synthetic mechanism of a major fluorescent adduct. Arch. Biochem. Biophys. 1997; 344: 29.
58. Kalapos MP. Methylglyoxal in living organisms chemistry, biochemistry, toxicology and biological implications. Toxicol. Lett. 1999; 110: 145.
59. Thornalley PJ, Yurek-George A, Argirov OK. Kinetics and mechanism of the reaction of aminoguanidine with alpha-oxoaldehydes glyoxal, methylglyoxal, and 3-deoxyglucosone under physiological conditions. Biochem. Pharmacol. 2000; 60: 55, DOI: 10.1016/30006-2952(00)002887-2.
60. Nemet I, Viki-Topic D, Varga-Defterdarovic L. Spectroscopic studies of methylglyoxal in water and dimethylsulf oxide. Bioorg. Chem. 2004; 32: 560, DOI: 10.1016/j.bioorg.2004.05.008.